Industry Insights

1. Conquer Study Start-Up Delays With A Data-Driven Approach
   6/22/2018

   Study start-up delays have perplexed the best minds in the clinical trials industry for decades. Discover how advanced analytics and an intense focus on the four problem areas can help.

2. A Proactive Approach To Ebola Vaccine Development
   6/21/2018

   Best practices for rapid test development and regulatory approvals.

3. Study Stakeholder Collaboration Takes The Stage At DIA
   6/21/2018

   A strategy to reduce potential conflicts when working with clinical research study stakeholders.

4. Fighting Cancer: Biomarkers For Immuno-Oncology Clinical Trials
   6/21/2018

   Using anatomic pathology for biomarker development in clinical trials can help predict and assess how a patient will respond to immuno-oncology therapies

5. DIA Panel Preview: Thinking Pragmatically About The Future Of Real World Evidence
   6/20/2018

   Questions and concerns as the FDA prepares to develop and implement a program evaluating the potential use of Real World Evidence (RWE) for regulatory decisions.

6. Three Things eClinical Providers Owe Their Users
   6/18/2018

   Three essential things for data managers to look for - and for technology providers like us to deliver - as clinical trial technology becomes more prevalent and diverse.

7. Immunotherapy And PD-L1: The Future Of Precision Medicine
   6/14/2018

   Advances in precision medicine lead to new trends in immunotherapy.

8. Using Advanced Techniques For Protein Bioanalysis
   6/14/2018

   Overcoming hurdles in a regulated setting.

9. Five Considerations For Sites Preparing For eConsent
   6/12/2018

   Five areas to investigate to determine whether your site is ready based on the 2016 FDA-OHRP guidance about eConsents.

10. Subject Recruitment Materials: Understanding The Requirements For IRB Review
    6/11/2018

    A breakdown of regulatory guidances and a clear picture of what the IRB needs to see.